COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02045368
Recruitment Status : Completed
First Posted : January 24, 2014
Last Update Posted : August 22, 2019
Information provided by (Responsible Party):
IGF Oncology, LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 30, 2016
Actual Study Completion Date : September 30, 2016